CLBCX
Price
$34.97
Change
+$0.21 (+0.60%)
Updated
Jan 17 closing price
Net Assets
240.18B
RLBGX
Price
$35.03
Change
+$0.22 (+0.63%)
Updated
Jan 17 closing price
Net Assets
240.18B
Ad is loading...

CLBCX vs RLBGX

Header iconCLBCX vs RLBGX Comparison
Open Charts CLBCX vs RLBGXBanner chart's image
American Funds American Balanced 529C
Price$34.97
Change+$0.21 (+0.60%)
VolumeN/A
Net Assets240.18B
American Funds American Balanced R6
Price$35.03
Change+$0.22 (+0.63%)
VolumeN/A
Net Assets240.18B
CLBCX vs RLBGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CLBCX vs. RLBGX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLBCX is a Buy and RLBGX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
CLBCX (240B) and RLBGX (240B) have equal amount of cash in the bank . RLBGX pays higher dividends than CLBCX: RLBGX (2.55) vs CLBCX (1.52). CLBCX was incepted earlier than RLBGX: CLBCX (23 years) vs RLBGX (16 years). CLBCX (171.00) and RLBGX (171.00) have comparable annual turnover. CLBCX (250) and RLBGX (250) have matching initial minimum investment requirements. RLBGX annual gain was more profitable for investors over the last year : 12.67 vs. CLBCX (11.42). RLBGX return over 5 years is better than : 31.72 vs. CLBCX (26.62).
CLBCXRLBGXCLBCX / RLBGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years16 years-
Gain YTD1.8941.98096%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets240B240B100%
Annual Yield % from dividends1.522.5560%
Returns for 1 year11.4212.6790%
Returns for 3 years11.2413.2385%
Returns for 5 years26.6231.7284%
Returns for 10 years56.7859.0296%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROK286.605.64
+2.01%
Rockwell Automation
SANM82.970.41
+0.50%
Sanmina Corp
YMAB6.16-0.02
-0.32%
Y-mAbs Therapeutics
SABS3.53-0.03
-0.84%
SAB Biotherapeutics
ALEX17.55-0.16
-0.90%
Alexander & Baldwin